Gene expression of inflammatory mediators implicated in AKI such as CXCL-1, CXCL-2, IL-1β, IL-6, TNF-α and RANTES were not significantly altered by Pepstatin A treatment (Fig. 5B,C and Suppl. This evidence concerns the gene CXCL2 and acute kidney injury.